Phoevos Hughes is a seasoned clinical operations executive with over a decade of experience in the pharmaceutical and biotechnology sectors. Currently serving as Vice President of Clinical Operations at a biosciences firm based in Indianapolis, he provides strategic leadership and operational oversight for clinical trials across a range of therapeutic areas, including necrotizing enterocolitis and autism spectrum disorder. With deep expertise in global regulatory frameworks, Mr. Hughes has successfully contributed to numerous regulatory submissions, including those for orphan drug designation, fast track designation, and breakthrough therapy programs. His work spans the full clinical development lifecycle, from early-phase, first-in-human trials to late-stage development and commercialization.

In addition to his executive role, Mr. Hughes is an active consultant, supporting emerging biotech companies focused on rare and underserved diseases. He partners with cross-functional teams to build scalable trial infrastructure, optimize operational performance, and ensure regulatory compliance.

Mr. Hughes holds a BS in Chemistry from York University and a JD from the University of Toledo College of Law.

Phoevos Hughes